This development follows extensive actions by industry advocates and organizations such as the Natural Products Association (NPA), which challenged the FDA's previous stance that NMN was initially investigated as a drug and therefore could not be marketed as a dietary supplement. Through a citizen petition, legal action, and mobilization of industry and consumer support, the NPA demonstrated that NMN has been marketed as a dietary supplement in the US since 2017 and is thus consistent with the definitions under DSHEA.
A key factor in this landmark decision was the recognition that NMN is a naturally occurring molecule that the body produces on its own as part of the NAD+ biosynthesis pathway. This fundamental characteristic underscores NMN's appropriate classification as a dietary supplement rather than a pharmaceutical drug.
The FDA's acknowledgment affirms that NMN products are compliant with dietary supplement regulations, marking a pivotal moment for supplement companies and consumers alike. Importantly, this decision protects consumers from the substantially increased costs that would have resulted from pharmaceutical monopolization of this natural compound, ensuring continued affordable access to this vital cellular health nutrient.
Bryan Nettles, CEO of Renue by Science, shared his thoughts on the victory:
"This is a historic day for both the supplement industry and the consumers we serve. The FDA's reversal confirms what we've known all along, that NMN is a safe, effective, and lawful supplement for promoting healthy aging and vitality. This decision protects consumers from inflated pharmaceutical pricing while safeguarding the pathways for future innovation in the supplement industry. We are grateful for the efforts of industry advocates and remain committed to providing innovative, science-backed products that support people's wellness journeys."
This regulatory clarity not only ensures continued access to NMN but also sets an important precedent that will protect future innovations in the dietary supplement space. The decision demonstrates that naturally occurring compounds essential to human health belong in the supplement category, where they can be accessed affordably by all who seek to support their cellular health and longevity.
As Renue by Science continues to lead with scientifically validated products, this victory reinforces our dedication to transparency, consumer choice, and the ongoing pursuit of health innovation.
About Renue by Science
Renue By Science is committed to advancing longevity science by making the latest breakthroughs globally accessible. We specialize in developing innovative supplement formulations that enhance rejuvenation and optimize energy production, empowering individuals to not only extend their lifespan but also improve their quality of life. Our mission is to harness research-backed ingredients and integrate them into bioavailable delivery systems that enhance both health span and lifespan.
To learn more about Renue by Science products, visit www.renuebyscience.com
For media inquiries: contact@renuebyscience.com
